ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 42 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,249,000 | +29.3% | 3,380,000 | +15.2% | 0.62% | +88.7% |
| Q2 2017 | $2,513,000 | +18.3% | 2,935,000 | +16.7% | 0.33% | +3.8% |
| Q1 2017 | $2,125,000 | -75.0% | 2,515,000 | -77.5% | 0.32% | -75.4% |
| Q4 2016 | $8,512,000 | +32.2% | 11,200,000 | +41.8% | 1.28% | +35.3% |
| Q3 2016 | $6,439,000 | +73.4% | 7,900,000 | +85.9% | 0.95% | +65.0% |
| Q2 2016 | $3,713,000 | -29.2% | 4,250,000 | -6.6% | 0.58% | -25.9% |
| Q4 2015 | $5,243,000 | +8.4% | 4,550,000 | -14.9% | 0.78% | -2.9% |
| Q3 2015 | $4,837,000 | -40.6% | 5,345,000 | -33.6% | 0.80% | -36.0% |
| Q2 2015 | $8,147,000 | -25.1% | 8,050,000 | -24.4% | 1.25% | -21.4% |
| Q1 2015 | $10,877,000 | +71.8% | 10,650,000 | +93.6% | 1.59% | +57.0% |
| Q4 2014 | $6,332,000 | +23.0% | 5,500,000 | +10.0% | 1.01% | +28.1% |
| Q3 2014 | $5,150,000 | – | 5,000,000 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
| Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
| Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
| Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
| Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
| SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
| Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
| CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |